Pediatr Allergy Respir Dis.  2011 Dec;21(4):319-325.

Factors Influencing Recurrent Wheezing in Infants: The Relationship between Respiratory Syncytial Virus Infections and the Development of Recurrent Wheezing

Affiliations
  • 1Department of Pediatrics, Wallace Memorial Baptist Hospital, Busan, Korea. khjwood@hanmail.net
  • 2Department of Pediatrics, Marynoll Medical Center, Busan, Korea.
  • 3Department of Occupational and Environmental Medicine, Dongguk University Gyeongju Hospital, Dongguk University College of Medicine, Gyeongju, Korea.

Abstract

PURPOSE
This study investigated factors affecting recurrent wheezing in infants, focusing on whether or not respiratory syncytial virus (RSV) infections in children <3 years of age induce recurrent wheezing later in life.
METHODS
The inclusion criteria were children <3 years of age who were hospitalized for an RSV infection from January 2006 to December 2009. We evaluated lateral flow immunochromatography (RSV Respi-Strip test). Subjects with at least three episodes of physician-verified wheezing were defined as recurrent wheezers. A group of 79 children hospitalized with RSV infections were compared with a matched control group. The following data were collected: age, gender, admission duration, gestational age, obesity, history of atopic dermatitis, parental history of allergic diseases, exposure to passive smoking, exposure to indoor animals, and daycare attendance.
RESULTS
Rates of obesity and exposure to passive smoking were significantly higher in the RSV group than those in the control group. The frequency of recurrent wheezing in the RSV group (39.2%) was higher than that in the control group (10.1%). Compared to the control group, recurrent wheezing occurred 5.76 times more often in the RSV group, 2.49 times more often in males, and 2.41 times often in patients with a parental history of allergic diseases.
CONCLUSION
The results demonstrated that RSV infection is significantly associated with recurrent wheezing, and that the risk is higher in male children and in children with a parental history of allergic diseases.

Keyword

Respiratory Syncytial Virus; Recurrent Wheezing

MeSH Terms

Animals
Child
Dermatitis, Atopic
Gestational Age
Humans
Immunochromatography
Infant
Male
Obesity
Parents
Respiratory Sounds
Respiratory Syncytial Virus Infections
Respiratory Syncytial Viruses
Tobacco Smoke Pollution
Tobacco Smoke Pollution

Reference

References

1. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998; 351:1225–32.
2. Heymann PW, Carper HT, Murphy DD, Platts-Mills TA, Patrie J, McLaughlin AP, et al. Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004; 114:239–47.
Article
3. Johnston SL. The role of viral and atypical bacterial pathogens in asthma pathogenesis. Pediatr Pulmonol Suppl. 1999; 18:141–3.
Article
4. McIntosh K, Ellis EF, Hoffman LS, Lybass TG, Eller JJ, Fulginiti VA. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr. 1973; 82:578–90.
Article
5. Schauer U, Hoffjan S, Bittscheidt J, Köchling A, Hemmis S, Bongartz S, et al. RSV bronchiolitis and risk of wheeze and allergic sensitisation in the first year of life. Eur Respir J. 2002; 20:1277–83.
Article
6. Hall CB, McCarthy CA. Respiratory syncytial virus. Mandell GL, Bennett JE, Dolin R, editors. editors.Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th Ed.Philadelphia: Churchill Livingstone Inc.;2000. p. 1782–801.
7. Simoes EA. Respiratory syncytial virus infection. Lancet. 1999; 354:847–52.
Article
8. Henderson FW, Collier AM, Clyde WA Jr, Denny FW. Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med. 1979; 300:530–4.
9. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009; 360:588–98.
Article
10. Kumar A, Grayson MH. The role of viruses in the development and exacerbation of atopic disease. Ann Allergy Asthma Immunol. 2009; 103:181–6.
Article
11. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med. 1998; 157(6 Pt 1):1708–20.
Article
12. Lemanske RF Jr, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005; 116:571–7.
13. Psarras S, Papadopoulos NG, Johnston SL. Pathogenesis of respiratory syncytial virus bronchiolitis-related wheezing. Paediatr Respir Rev. 2004; 5(Suppl A)::S179–84.
Article
14. De Silva LM, Hanlon MG. Respiratory syncytial virus: a report of a 5-year study at a children's hospital. J Med Virol. 1986; 19:299–305.
15. Kimpen JL, Simoes EA. Respiratory syncytial virus and reactive airway disease. New developments prompt a new review. Am J Respir Crit Care Med. 2001; 163(3 Pt 2):): S1.
16. Piedimonte G. Neural mechanisms of respiratory syncytial virus-induced inflammation and prevention of respiratory syncytial virus sequelae. Am J Respir Crit Care Med. 2001; 163(3 Pt 2):S18–21.
Article
17. Welliver RC, Wong DT, Sun M, Middleton E Jr, Vaughan RS, Ogra PL. The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N Engl J Med. 1981; 305:841–6.
Article
18. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003; 143(5 Suppl):S118–26.
Article
19. Yau KI, Fang LJ, Shieh KH. Factors predisposing infants to lower respiratory infection with wheezing in the first two years of life. Ann Allergy Asthma Immunol. 1999; 82:165–70.
Article
20. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD. Tucson children's respiratory study: 1980 to present. J Allergy Clin Immunol. 2003; 111:661–75.
Article
21. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007; 119:1105–10.
Article
22. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995; 332:133–8.
23. Meissner HC, Long SS. Respiratory syncytial virus infection and recurrent wheezing: a complex relationship. J Pediatr. 2007; 151:6–7.
Article
24. Han J, Jia Y, Takeda K, Shiraishi Y, Okamoto M, Dakhama A, et al. Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus. Am J Respir Crit Care Med. 2010; 182:455–63.
Article
25. Proesmans M, Sauer K, Govaere E, Raes M, De Bilderling G, De Boeck K. Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis. Acta Paediatr. 2009; 98:1830–4.
Article
Full Text Links
  • PARD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr